An Updated View on the Antiviral Therapy of Hepatitis C in Chronic Kidney Disease
Background: Hepatitis C virus infection remains common in patients with chronic kidney disease, including those on maintenance dialysis. The relationship between hepatitis C virus infection and chronic kidney disease is bi-directional; in fact, HCV is both a cause and consequence of chronic kidney d...
Saved in:
Main Authors: | Fabrizio Fabrizi, Roberta Cerutti, Piergiorgio Messa |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c2faed92fb824559a1e6e699aa65e3b6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant
by: Fabrizio Fabrizi, et al.
Published: (2021) -
Hepatitis aguda por virus C: reporte de siete casos en centro de referencia en Chile
by: Urzúa,Álvaro, et al.
Published: (2020) -
Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
by: Vicente Soriano, et al.
Published: (2022) -
Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment
by: María E. Cárdaba-García, et al.
Published: (2021) -
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy
by: Cesare Mazzaro, et al.
Published: (2021)